Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥8,650 JPY
Change Today +230.00 / 2.73%
Volume 106.4K
4967 On Other Exchanges
As of 2:00 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

kobayashi pharmaceutical co (4967) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/11/15 - ¥8,930
52 Week Low
04/11/14 - ¥5,750
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KOBAYASHI PHARMACEUTICAL CO (4967)

Related News

No related news articles were found.

kobayashi pharmaceutical co (4967) Related Businessweek News

No Related Businessweek News Found

kobayashi pharmaceutical co (4967) Details

Kobayashi Pharmaceutical Co., Ltd. develops, produces, and sells OTC pharmaceuticals, oral hygiene products, food products, deodorizing air fresheners, sanitary products, household sundries, and body warmers in Japan and internationally. The company operates through four segments: Consumer Products, Mail Order, Medical Devices, and Other Business. The Consumer Products segment offers pharmaceuticals, oral hygiene products, sanitary products, deodorizing air fresheners, household sundries, food products, and body warmers. The Mail Order segment sells nutritional supplements, skincare products, and related items. The Medical Devices segment sells medical equipment. The Other Business segment manufactures and distributes synthetic resin containers, as well as offers transportation, insurance agency, real estate management, and advertisement planning and production services. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

2,364 Employees
Last Reported Date: 06/27/14
Founded in 1886

kobayashi pharmaceutical co (4967) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: ¥245.0M
Compensation as of Fiscal Year 2014.

kobayashi pharmaceutical co (4967) Key Developments

Kobayashi Pharmaceutical Co. Ltd. Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015

Kobayashi Pharmaceutical Co. Ltd. Presents at Mizuho New York Healthcare Conference 2015, Mar-02-2015 . Venue: Omni Berkshire Place, 21 East 52nd Street at Madison Ave, New York, NY 10022, United States. Speakers: Yutaka Kobayashi, Vice Chairman.

Kobayashi Pharmaceutical Co. Ltd. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

Kobayashi Pharmaceutical Co. Ltd. announced consolidated earnings results for the nine months ended December 31, 2014. For the period, the company reported net sales of JPY 97,154 million against JPY 95,726 million a year ago. Operating income JPY 14,950 million against JPY 15,064 million a year ago. Ordinary income was JPY 15,751 million against JPY 15,510 million a year ago. Net income was JPY 10,672 million or JPY 261.80 per share against JPY 10,249 million or JPY 250.30 per share a year ago. Income before income taxes was JPY 16,020 million against JPY 15,973 million a year ago. For the year ending March 31, 2015, the company expects net sales of JPY 132,000 million, operating income of JPY 18,400 million, ordinary income of JPY 19,000 million and net income of JPY 12,500 million or JPY 305.27 per share.

Kobayashi Pharmaceutical Co. Ltd. to Report Q3, 2015 Results on Feb 06, 2015

Kobayashi Pharmaceutical Co. Ltd. announced that they will report Q3, 2015 results on Feb 06, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4967:JP ¥8,650.00 JPY +230.00

4967 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4967.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4967 Industry Range
Price/Earnings 27.1x
Price/Sales 2.7x
Price/Book 2.6x
Price/Cash Flow 26.0x
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOBAYASHI PHARMACEUTICAL CO, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at